CTNM
Contineum Therapeutics, Inc. Class A Common Stock
There isn't enough reported data to score CTNM yet.
CTNM Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Strong |
CTNM's balance sheet is currently strong, but its profitability is weak. There isn't enough data to rate its revenue and cash flow.
CTNM PE Valuation
CTNM has no meaningful PE right now: it lost money over the past year.
CTNM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong decline | |
| -- | |
| Limited | |
| Moderate |
Analysts expect CTNM's revenue to decline, with its earnings and profitability holding steady.
CTNM Earnings Per Share
CTNM has swung to a loss: it lost $1.76 per share over the past year, after a profit the year before.
CTNM Quarterly Revenue
CTNM's revenue has slid since its 2023 peak: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2023 | 78% | N/A |
CTNM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$11.1M | +$1.2M |
| Q2 2026 | -$11.5M | +$4.2M |
| Q1 2026 | -$16.6M | -$2.1M |
| Q4 2025 | -$13.1M | -$2.7M |
| Q3 2025 | -$12.3M | -$6M |
| Q2 2025 | -$15.7M | -$7.1M |
| Q1 2025 | -$14.5M | -$6.3M |
| Q4 2024 | -$10.4M | +$645K |
CTNM has burned cash in almost every quarter: −$52M over the past year, against −$53M the year before.
CTNM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.5% | +922K shares |
| 1 year | +48% | +12.5M shares |
| 3 years | +53% | +13.3M shares |
CTNM has 38M diluted shares, up 48% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | $1,000 |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
CTNM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2024 | -0.9x | Net Cash |
| Q4 2023 | 7.5x | High |
| Q3 2023 | 7.3x | High |
CTNM has more cash than debt.
CTNM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.9 | Neutral |
| Stochastic | 25.6 | Neutral |
CTNM's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
CTNM PE vs Healthcare Sector
CTNM has no meaningful PE right now: it lost money over the past year.
CTNM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.4 | 5.9% below |
| 20 week MA | $13.3 | 26% below |
| 50 week MA | $13.1 | 25% below |
| 100 week MA | $10.7 | 8.3% below |
CTNM is in a downtrend: it's below all four of its weekly moving averages, and 8.3% below its 100-week average.
CTNM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $15.4 | $14.4 | -6.5% |
| 2025 | $14.4 | $12.4 | -14% |
| 2026 YTD | $12.4 | $9.78 | -21% |
CTNM has finished every year since 2024 lower, and it's down 21% so far in 2026.